<- Go Home

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally.

Market Cap

$43.4B

Volume

4.6M

Cash and Equivalents

$3.7B

EBITDA

$2.1B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$4.8B

Profit Margin

76.60%

52 Week High

$96.12

52 Week Low

$58.93

Dividend

N/A

Price / Book Value

4.54

Price / Earnings

28.36

Price / Tangible Book Value

6.21

Enterprise Value

$39.7B

Enterprise Value / EBITDA

19.05

Operating Income

$1.9B

Return on Equity

19.14%

Return on Assets

10.65

Cash and Short Term Investments

$4.4B

Debt

$706.7M

Equity

$9.6B

Revenue

$6.3B

Unlevered FCF

$1.8B

Sector

Health Care Equipment and Supplies

Category

N/A

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches